metodebok.no  Kreft
/
 

Behandling av lokalisert sykdom / kurativ behandling

Behandling av lokalisert sykdom / kurativ behandling

Sist oppdatert: 28.03.2025
Mer informasjon
Utgiver: Helsedirektoratet
Versjon: 1.0
Kopier lenke til dette emnet
Foreslå endringer/gi kommentarer

Utredning, vurdering og behandling av pancreaskreftpasienter bør foregå på sentra med adekvat spesialkompetanse som samarbeider i multidisiplinære team, og som har døgnkontinuerlig kompetent vakt innen alle fagområder som er involvert i behandlingen.

Referanser 

Adiamah, A., Arif, Z., Berti, F., Singh, S., Laskar, N., & Gomez, D. (2019). The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials. World Journal of Surgery, 43(7), 1788-1801.
Adsay, V., Mino-Kenudson, M., Furukawa, T., Basturk, O., Zamboni, G., Marchegiani, G., ... Hruban, R. H. (2016). Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. Annals of Surgery, 263(1), 162-77.
Aliseda, D., Marti-Cruchaga, P., Zozaya, G., Blanco, N., Ponz, M., Chopitea, A., ... Rotellar, F. (2024). Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis of randomized clinical trials. BJS Open, 8(5)
American College of Surgeons and the Alliance for Clinical Trials in Oncology, Nelson, H., ... Halverson, A. (2015). Operative Standards for Cancer Surgery: Volume 1: Breast, lung, pancreas, colon. Walters Kluwer.
Bassi, C., Marchegiani, G., Dervenis, C., Sarr, M., Abu Hilal, M., Adham, M., ... International Study Group on Pancreatic, S. (2017). The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery, 161(3), 584-591.
Basturk, O., Hong, S. M., Wood, L. D., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., ... Furukawa, T. (2015). A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. American journal of surgical pathology, 39(12), 1730-41.
Besselink, M. G., van Rijssen, L. B., Bassi, C., Dervenis, C., Montorsi, M., Adham, M., ... International Study Group on Pancreatic, S. (2017). Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery. Surgery, 161(2), 365-372.
Brennan, M. F., Pisters, P. W., Posner, M., Quesada, O., & Shike, M. (1994). A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Annals of Surgery, 220(4), 436-41; discussion 441-4.
Brierley, J. D., Gospodarowicz, M., & Wettekind, C. (2017). TNM: Classification of Malignant Tumors. Wiley-Blackwell.
Campbell, F., Verbeke, C. S. (2021). Pathology of the Pancreas: a Practical Approach. (2 utg.). Cham: Springer.
Chandrasegaram, M. D., Goldstein, D., Simes, J., Gebski, V., Kench, J. G., Gill, A. J., ... Barbour, A. P. (2015). Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. British journal of surgery, 102(12), 1459-72.
Christians, K. K., Tsai, S., Tolat, P. P., & Evans, D. B. (2013). Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinoma. Journal of surgical oncology, 107(1), 33-8.
Cloyd, J. M., Shen, C., Santry, H., Bridges, J., Dillhoff, M., Ejaz, A., ... Tsung, A. (2020). Disparities in the Use of Neoadjuvant Therapy for Resectable Pancreatic Ductal Adenocarcinoma. Journal of the National Comprehensive Cancer Network, 18(5), 556-563.
Conroy, T., Castan, F., Lopez, A., Turpin, A., Ben Abdelghani, M., Wei, A. C., ... the Unicancer, G. I. P. G. (2022). Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial. JAMA Oncology, 8(11), 1571-1578.
Conroy, T., Desseigne, F., Ychou, M., Bouche, O., Guimbaud, R., Becouarn, Y., ... Ducreux, M. (2011). FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. New England Journal of Medicine, 364(19), 1817-1825.
Conroy, T., Hammel, P., Hebbar, M., Ben Abdelghani, M., Wei, A. C., Raoul, J. L., ... the Unicancer, G. I. P. G. (2018). FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. New England Journal of Medicine, 379(25), 2395-2406.
Conroy, T., Pfeiffer, P., Vilgrain, V., Lamarca, A., Seufferlein, T., O'Reilly, E. M., ... clinicalguidelines@esmo.org, E. G. C. E. a. (2023). Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology, 34(11), 987-1002.
Del Chiaro, M., Verbeke, C., Salvia, R., Kloppel, G., Werner, J., McKay, C., ... Segersvard, R. (2013). European experts consensus statement on cystic tumours of the pancreas. Digestive and Liver Disease, 45(9), 703-11.
Dennis, J. L., Hvidsten, T. R., Wit, E. C., Komorowski, J., Bell, A. K., Downie, I., ... Oien, K. A. (2005). Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clinical Cancer Research, 11(10), 3766-72.
Deshpande, V., Konstantinidis, I. T., Castillo, C. F., Hezel, A. F., Haigis, K. M., Ting, D. T., ... Ferrone, C. R. (2016). Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Surgery, 20(5), 953-9.
Diener, M. K., Mehr, K. T., Wente, M. N., Kieser, M., Buchler, M. W., & Seiler, C. M. (2011). Risk-benefit assessment of closed intra-abdominal drains after pancreatic surgery: a systematic review and meta-analysis assessing the current state of evidence. Langenbeck's Archives of Surgery, 396(1), 41-52.
Dumonceau, J. M., Tringali, A., Papanikolaou, I. S., Blero, D., Mangiavillano, B., Schmidt, A., ... van Hooft, J. E. (2018). Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017. Endoscopy, 50(9), 910-930.
Farnes, I., Kleive, D., Verbeke, C. S., Aabakken, L., Issa-Epe, A., Smastuen, M. C., ... Labori, K. J. (2023). Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2). BJS Open, 7(6)
Ferrone, C. R., Marchegiani, G., Hong, T. S., Ryan, D. P., Deshpande, V., McDonnell, E. I., ... Fernandez-del Castillo, C. (2015). Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Annals of Surgery, 261(1), 12-7.
Fong, Z. V., Ferrone, C. R., Lillemoe, K. D., & Fernandez-Del Castillo, C. (2016). Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current State of the Art and Ongoing Controversies. Annals of Surgery, 263(5), 908-17.
Ghaneh, P., Palmer, D., Cicconi, S., Jackson, R., Halloran, C. M., Rawcliffe, C., ... European Study Group for Pancreatic, C. (2023). Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. Lancet. Gastroenterology & hepatology, 8(2), 157-168.
Gianotti, L., Besselink, M. G., Sandini, M., Hackert, T., Conlon, K., Gerritsen, A., ... Bassi, C. (2018). Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS). Surgery, 164(5), 1035-1048.
Hammad, A. Y., Hodges, J. C., AlMasri, S., Paniccia, A., Lee, K. K., Bahary, N., ... Zureikat, A. (2023). Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy. JAMA Surgery, 158(1), 55-62.
Hartwig, W., Hackert, T., Hinz, U., Gluth, A., Bergmann, F., Strobel, O., ... Werner, J. (2011). Pancreatic cancer surgery in the new millennium: better prediction of outcome. Annals of Surgery, 254(2), 311-319.
Helsedirektoratet (2024-10-12T00:00:00). Antibiotika i sykehus: nasjonal faglig retningslinje. [nettdokument]. Oslo: Helsedirektoratet. Hentet 2025-04-03 fra https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-sykehus
Hruban, R. H., & Klimstra, D. S. (2014). Adenocarcinoma of the pancreas. Seminars in diagnostic pathology, 31(6), 443-51.
Huang, L., Jansen, L., Balavarca, Y., Babaei, M., van der Geest, L., Lemmens, V., ... Brenner, H. (2018). Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study. BMC Medicine, 16(1), 125.
Isaji, S., Mizuno, S., Windsor, J. A., Bassi, C., Fernandez-Del Castillo, C., Hackert, T., ... Wolfgang, C. L. (2017). International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology
Javed, A. A., Mahmud, O., Fatimi, A. S., Habib, A., Grewal, M., He, J., ... Consortium, P. (2024). Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology, 31(7), 4673-4687.
Kakar, S., Shi, C., Adsay, N. V., Fitzgibbons, P., Frankel, W. L., Klimstra, D. S., Krasinskas, A. M., Mino-Kenudson, M., Pawlik, T., Vauthey, J. N., Washington, M. K. (2017). Protocol for the Examination of Specimens From Patients With Carcinoma of the Pancreas. Northfield, Ill: College of American Pathologists. Hentet fra https://documents.cap.org/protocols/cp-gihepatobiliary-pancreas-exocrine-17protocol-4001.pdf
Katz, M. H., Fleming, J. B., Bhosale, P., Varadhachary, G., Lee, J. E., Wolff, R., ... Balachandran, A. (2012). Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer, 118(23), 5749-5756.
Katz, M. H. G., Shi, Q., Meyers, J., Herman, J. M., Chuong, M., Wolpin, B. M., ... O'Reilly, E. M. (2022). Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial. JAMA Oncology, 8(9), 1263-1270.
Kleive, D., Labori, K. J., Line, P. D., Gladhaug, I. P., & Verbeke, C. S. (2020). Pancreatoduodenectomy with venous resection for ductal adenocarcinoma rarely achieves complete (R0) resection. HPB (Oxford), 22(1), 50-57.
Kleive, D., Sahakyan, M. A., Berstad, A. E., Verbeke, C. S., Gladhaug, I. P., Edwin, B., ... Labori, K. J. (2017). Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy. British journal of surgery, 104(11), 1558-1567.
Kleive, D., Sahakyan, M. A., Khan, A., Fosby, B., Line, P. D., & Labori, K. J. (2018). Incidence and management of arterial injuries during pancreatectomy. Langenbeck's Archives of Surgery, 403(3), 341-348.
Klompmaker, S., Boggi, U., Hackert, T., Salvia, R., Weiss, M., Yamaue, H., ... Besselink, M. G. (2018). Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) for Pancreatic Cancer. How I do It. Journal of Gastrointestinal Surgery, 22(10), 1804-1810.
Klompmaker, S., van Hilst, J., Gerritsen, S. L., Adham, M., Teresa Albiol Quer, M., Bassi, C., ... group, E. A. D. s. (2018). Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Annals of Surgical Oncology, 25(5), 1440-1447.
Koch, M., Garden, O. J., Padbury, R., Rahbari, N. N., Adam, R., Capussotti, L., ... Weitz, J. (2011). Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery, 149(5), 680-8.
Korrel, M., Jones, L. R., van Hilst, J., Balzano, G., Bjornsson, B., Boggi, U., ... European Consortium on Minimally Invasive Pancreatic, S. (2023). Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Lancet Regional Health. Europe, 31, 100673.
Kreftregisteret (2024). Årsrapport 2023: resultater og forbedringstiltak fra Kvalitetsregister for pankreaskreft. Oslo: Kreftregisteret. Hentet fra https://www.kreftregisteret.no/globalassets/publikasjoner-og-rapporter/arsrapporter/publisert-2024/arsrapport-2023-kvalitetsregister-for-pankreaskreft.pdf
Labori, K. J., Bratlie, S. O., Andersson, B., Angelsen, J. H., Biorserud, C., Bjornsson, B., ... Nordic Pancreatic Cancer Trial-1 study, g. (2024). Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial. Lancet. Gastroenterology & hepatology, 9(3), 205-217.
Labori, K. J., Kleive, D., Khan, A., Farnes, I., Fosby, B., & Line, P. D. (2021). Graft type for superior mesenteric and portal vein reconstruction in pancreatic surgery - A systematic review. HPB (Oxford), 23(4), 483-494.
Lassen, K., Kjaeve, J., Fetveit, T., Trano, G., Sigurdsson, H. K., Horn, A., & Revhaug, A. (2008). Allowing normal food at will after major upper gastrointestinal surgery does not increase morbidity: a randomized multicenter trial. Annals of Surgery, 247(5), 721-729.
Latenstein, A. E. J., Scholten, L., Al-Saffar, H. A., Bjornsson, B., Butturini, G., Capretti, G., ... Scientific, R. C. o. t. E. H. A. (2022). Clinical Outcomes After Total Pancreatectomy: A Prospective Multicenter Pan-European Snapshot Study. Annals of Surgery, 276(5), e536-e543.
Liu, H., Shi, J., Anandan, V., Wang, H. L., Diehl, D., Blansfield, J., ... Lin, F. (2012). Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas. Archives of pathology & laboratory medicine, 136(6), 601-9.
Maggino, L., Malleo, G., Marchegiani, G., Viviani, E., Nessi, C., Ciprani, D., ... Salvia, R. (2019). Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma. JAMA Surgery, 154(10), 932-942.
Mansfield, S. D., Sen, G., Oppong, K., Jacques, B. C., O'Suilleabhain, C. B., Manas, D. M., & Charnley, R. M. (2006). Increase in serum bilirubin levels in obstructive jaundice secondary to pancreatic and periampullary malignancy--implications for timing of resectional surgery and use of biliary drainage. HPB (Oxford), 8(6), 442-5.
Marangoni, G., Morris-Stiff, G., Deshmukh, S., Hakeem, A., & Smith, A. M. (2012). A modern approach to teaching pancreatic surgery: stepwise pancreatoduodenectomy for trainees. Journal of Gastrointestinal Surgery, 16(8), 1597-1604.
Matthaei, H., Hong, S. M., Mayo, S. C., dal Molin, M., Olino, K., Venkat, R., ... Hruban, R. H. (2011). Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Annals of Surgical Oncology, 18(12), 3493-9.
McMillan, M. T., Malleo, G., Bassi, C., Allegrini, V., Casetti, L., Drebin, J. A., ... Vollmer, C. M. ,. J. (2017). Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification. Annals of Surgery, 265(6), 1209-1218.
Melloul, E., Lassen, K., Roulin, D., Grass, F., Perinel, J., Adham, M., ... Demartines, N. (2020). Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019. World Journal of Surgery, 44(7), 2056-2084.
Michalski, C. W., Kleeff, J., Wente, M. N., Diener, M. K., Buchler, M. W., & Friess, H. (2007). Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. British journal of surgery, 94(3), 265-273.
Mollberg, N., Rahbari, N. N., Koch, M., Hartwig, W., Hoeger, Y., Buchler, M. W., & Weitz, J. (2011). Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Annals of Surgery, 254(6), 882-893.
NCCN (2020). NCCN Clinical Practical Guidelines in Oncology: Pancreas Adenocarcinoma. Version 1.2020. Washington, PA: National Comprehensive Cancer Network. Hentet fra https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455 (krever registrering)
NCCN (2024). NCCN Clinical Practical Guidelines in Oncology: Pancreas Adenocarcinoma. Version 3.2024. Washington, PA: National Comprehensive Cancer Network. Hentet fra https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455 (krever registrering)
Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., ... Buchler, M. W. (2017). Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet, 389(10073), 1011-1024.
Neoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., ... Buchler, M. W. (2010). Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA, 304(10), 1073-1081.
Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, J. A., Hickey, H., ... Buchler, M. W. (2004). A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. New England Journal of Medicine, 350(12), 1200-1210.
Norsk register for Gastrokirurgi (2024). Årsrapport 2023: resultater og forbedringstiltak. Tromsø: NORGAST. Hentet fra https://www.kvalitetsregistre.no/4a2cda/siteassets/dokumenter/arsrapporter/gastrokirurgiregisteret/arsrapport-2023-norgast.pdf
Nymo, L. S., Kleive, D., Waardal, K., Bringeland, E. A., Soreide, J. A., Labori, K. J., ... Lassen, K. (2020). Centralizing a national pancreatoduodenectomy service: striking the right balance. BJS Open, 4(5), 904-913.
Nymo, L. S., Myklebust, T. A., Hamre, H., Moller, B., & Lassen, K. (2022). Treatment and survival of patients with pancreatic ductal adenocarcinoma: 15-year national cohort. BJS Open, 6(2)
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., ... Riess, H. (2007). Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA, 297(3), 267-277.
Pedrazzoli, S. (2022). Surgical treatment of pancreatic cancer: Currently debated topics on morbidity, mortality, and lymphadenectomy. Surgical Oncology, 45, 101858.
Petrucciani, N., Nigri, G., Debs, T., Giannini, G., Sborlini, E., Antolino, L., ... Ramacciato, G. (2016). Frozen section analysis of the pancreatic margin during pancreaticoduodenectomy for cancer: Does extending the resection to obtain a secondary R0 provide a survival benefit? Results of a systematic review. Pancreatology, 16(6), 1037-1043.
Sabater, L., Ausania, F., Bakker, O. J., Boadas, J., Dominguez-Munoz, J. E., Falconi, M., ... de-Madaria, E. (2016). Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery. Annals of Surgery, 264(6), 949-958.
Sahakyan, M. A., Rosok, B. I., Tholfsen, T., Kleive, D., Waage, A., Ignjatovic, D., ... Edwin, B. (2022). Implementation and training with laparoscopic distal pancreatectomy: 23-year experience from a high-volume center. Surgical endoscopy, 36(1), 468-479.
Seufferlein, T., Uhl, W., Kornmann, M., Algul, H., Friess, H., Konig, A., ... Ettrich, T. J. (2023). Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group. Annals of Oncology, 34(1), 91-100.
Sohal, D. P. S., Duong, M., Ahmad, S. A., Gandhi, N. S., Beg, M. S., Wang-Gillam, A., ... Hochster, H. S. (2021). Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial. JAMA Oncology, 7(3), 421-427.
Soreide, K., Olsen, F., Nymo, L. S., Kleive, D., & Lassen, K. (2019). A nationwide cohort study of resection rates and short-term outcomes in open and laparoscopic distal pancreatectomy. HPB (Oxford), 21(6), 669-678.
Springfeld, C., Ferrone, C. R., Katz, M. H. G., Philip, P. A., Hong, T. S., Hackert, T., ... Neoptolemos, J. (2023). Neoadjuvant therapy for pancreatic cancer. Nature reviews. Clinical oncology, 20(5), 318-337.
Stoop, T. F., Sugawara, T., Oba, A., Feld, I. M., van Roessel, S., van Veldhuisen, E., ... International Collaboration on Advanced Pancreatic, C. (2025). Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX. JAMA Oncology
Stoop, T. F., Theijse, R. T., Seelen, L. W. F., Groot Koerkamp, B., van Eijck, C. H. J., Wolfgang, C. L., ... International Collaborative Group on Locally Advanced Pancreatic, C. (2024). Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer. Nature reviews. Gastroenterology & hepatology, 21(2), 101-124.
Tempero, M. A., Pelzer, U., O'Reilly, E. M., Winter, J., Oh, D. Y., Li, C. P., ... Investigators, A. (2023). Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial. Journal of Clinical Oncology, 41(11), 2007-2019.
Tol, J. A., Gouma, D. J., Bassi, C., Dervenis, C., Montorsi, M., Adham, M., ... Charnley, R. M. (2014). Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery, 156(3), 591-600.
Traverso, L. W., & Longmire, W. P. (1978). Preservation of the pylorus in pancreaticoduodenectomy. Surgery, Gynecology & Obstetrics, 146(6), 959-962.
Uijterwijk, B. A., Lemmers, D. H., Ghidini, M., Wilmink, H., Zaniboni, A., Salvia, R., ... Consortium, I. (2024). The Five Periampullary Cancers, not Just Different Siblings but Different Families: An International Multicenter Cohort Study. Annals of Surgical Oncology, 31(9), 6157-6169.
Valle, J. W., Palmer, D., Jackson, R., Cox, T., Neoptolemos, J. P., Ghaneh, P., ... Buchler, M. W. (2014). Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. Journal of Clinical Oncology, 32(6), 504-12.
van Bodegraven, E. A., Balduzzi, A., van Ramshorst, T. M. E., Malleo, G., Vissers, F. L., van Hilst, J., ... Dutch Pancreatic Cancer, G. (2024). Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial. Lancet. Gastroenterology & hepatology, 9(5), 438-447.
van der Gaag, N. A., Rauws, E. A., van Eijck, C. H., Bruno, M. J., van der Harst, E., Kubben, F. J., ... Gouma, D. J. (2010). Preoperative biliary drainage for cancer of the head of the pancreas. New England Journal of Medicine, 362(2), 129-37.
van Dijk, S. M., Heerkens, H. D., Tseng, D. S. J., Intven, M., Molenaar, I. Q., & van Santvoort, H. C. (2018). Systematic review on the impact of pancreatoduodenectomy on quality of life in patients with pancreatic cancer. HPB (Oxford), 20(3), 204-215.
van Roessel, S., van Veldhuisen, E., Klompmaker, S., Janssen, Q. P., Abu Hilal, M., Alseidi, A., ... European-African Hepato-Pancreato-Biliary, A. (2020). Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment. JAMA Oncology, 6(11), 1733-1740.
Verbeke, C. (2016). Morphological heterogeneity in ductal adenocarcinoma of the pancreas - Does it matter?. Pancreatology, 16(3), 295-301.
Verbeke, C., Brosens, L., Campbell, F., Del Chiaro, M., Esposito, I., Feakins, R. M., Fukushima, N., Gill, A., Kakar, S., Kench, J., Krasinkas, A. M., Van Laethem, J. L., Schaeffer, D. F., Washington, M. K. (2020). Carcinoma of the Exocrine Pancreas Histopathology Reporting Guide. Sydney: International Collaboration on Cancer Reporting. Hentet fra http://www.iccr-cancer.org/datasets/published-datasets/digestive-tract/pancreas
Verbeke, C., Haberle, L., Lenggenhager, D., & Esposito, I. (2018). Pathology assessment of pancreatic cancer following neoadjuvant treatment: Time to move on. Pancreatology
Verbeke, C. S. (2013). Resection margins in pancreatic cancer. Surgical Clinics of North America, 93(3), 647-62.
Verbeke, C. S., & Gladhaug, I. P. (2012). Resection margin involvement and tumour origin in pancreatic head cancer. British journal of surgery, 99(8), 1036-1049.
Verbeke, C. S., & Gladhaug, I. P. (2016). Dissection of pancreatic specimens. Surgical pathology clinics, 9(4), 523-538.
Versteijne, E., Suker, M., Groothuis, K., Akkermans-Vogelaar, J. M., Besselink, M. G., Bonsing, B. A., ... Dutch Pancreatic Cancer, G. (2020). Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial. Journal of Clinical Oncology, 38(16), 1763-1773.
Versteijne, E., van Dam, J. L., Suker, M., Janssen, Q. P., Groothuis, K., Akkermans-Vogelaar, J. M., ... Dutch Pancreatic Cancer, G. (2022). Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. Journal of Clinical Oncology, JCO2102233.
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., ... Renschler, M. F. (2013). Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. New England Journal of Medicine, 369(18), 1691-703.
Walma, M. S., Brada, L. J., Patuleia, S. I. S., Blomjous, J. G., Bollen, T. L., Bosscha, K., ... Dutch Pancreatic Cancer, G. (2021). Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort. European Journal of Surgical Oncology, 47(3 Pt B), 699-707.
Wang, F., Arianayagam, R., Gill, A., Puttaswamy, V., Neale, M., Gananadha, S., ... Samra, J. S. (2012). Grafts for mesenterico-portal vein resections can be avoided during pancreatoduodenectomy. Journal of the American College of Surgeons, 215(4), 569-579.
Wente, M. N., Bassi, C., Dervenis, C., Fingerhut, A., Gouma, D. J., Izbicki, J. R., ... Buchler, M. W. (2007). Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery, 142(5), 761-768.
Wente, M. N., Veit, J. A., Bassi, C., Dervenis, C., Fingerhut, A., Gouma, D. J., ... Buchler, M. W. (2007). Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery, 142(1), 20-25.
Whipple, A. O., Parsons, W. B., & Mullins, C. R. (1935). Treatment of Carcinoma of the Ampulla of Vater. Annals of Surgery, 102(4), 763-79.
Winter, J. M., Tang, L. H., Klimstra, D. S., Brennan, M. F., Brody, J. R., Rocha, F. G., ... Allen, P. J. (2012). A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. PLoS One, 7(7), e40157.
Worni, M., Castleberry, A. W., Clary, B. M., Gloor, B., Carvalho, E., Jacobs, D. O., ... White, R. R. (2013). Concomitant Vascular Reconstruction During Pancreatectomy for Malignant Disease: A Propensity Score-Adjusted, Population-Based Trend Analysis Involving 10 206 Patients. JAMA Surgery, 148, 331-338.
Xue, Y., Vanoli, A., Balci, S., Reid, M. M., Saka, B., Bagci, P., ... Adsay, V. (2017). Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas. Modern Pathology, 30(2), 255-266.
Yamasaki, S., Suda, K., Nobukawa, B., & Sonoue, H. (2002). Intraductal spread of pancreatic cancer. Clinicopathologic study of 54 pancreatectomized patients. Pancreatology, 2(4), 407-12.
Zwart, E. S., Yilmaz, B. S., Halimi, A., Ahola, R., Kurlinkus, B., Laukkarinen, J., & Ceyhan, G. O. (2022). Venous resection for pancreatic cancer, a safe and feasible option? A systematic review and meta-analysis. Pancreatology, 22(6), 803-809.

Personvernerklæring Ansvarsfordeling Redaktører og forfattere Om metodebok.no
App Store
Google Play